1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIPELLA PHARMACEUTICALS INC
Lipella Pharmaceuticals Inc XNAS: LIPO
Download real time
2.36 -0.34 (-12.59%)
80.33% Fall from 52W High
267.3K
XNAS Volume
High volume+loss today

XNAS 18 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Lipella Pharmaceuticals Inc

The latest disclosure was made by Jonathan Kaufman in Lipella Pharmaceuticals Inc where a trade of 4,060 Common Stock Purchase Warrants done was reported to US exchanges on April 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 03 Apr 2025 4,060 0 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 03 Apr 2025 536,959 0 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 03 Apr 2025 125,833 0 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 03 Apr 2025 28,924 0 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 13 Mar 2025 4,060 4,060 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 13 Mar 2025 10,326 536,959 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 10 Mar 2025 28,924 28,924 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 10 Mar 2025 84,700 526,633 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 28 Feb 2025 441,933 441,933 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 28 Feb 2025 125,833 125,833 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 15 Jan 2025 11,795 0 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 15 Jan 2025 85,421 0 - - Common Stock Purchase Warrants
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 15 Jan 2025 303,041 0 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 31 Dec 2024 42,933 303,041 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 31 Dec 2024 11,795 11,795 - - Common Stock Purchase Warrants
Kaufman Jonathan Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 23 Dec 2024 85,421 85,421 - - Common Stock Purchase Warrants
Kaufman Jonathan Director, See remarks below., Ten Percent Owner Other type of transaction at price $ 0.00 per share. 23 Dec 2024 260,108 260,108 - - Series C Voting Convertible Preferred Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.76 per share. 14 May 2024 10,000 898,849 - 0.8 7,590 Common Stock
Douglas Johnston Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 50,000 50,000 - - Stock Options
Byong Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 25,000 25,000 - - Stock Options
Ryan Pruchnic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 25,000 25,000 - - Stock Options
Naoki Yoshimura Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 25,000 25,000 - - Stock Options
Daniel R. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 25,000 25,000 - - Stock Options
Lori Birder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 25,000 25,000 - - Stock Options
Michael Chancellor Director, Chief Medical Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 80,000 80,000 - - Stock Options
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.87 per share. 15 Mar 2024 25,000 888,849 - 0.9 21,803 Common Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.79 per share. 15 Mar 2024 30,000 863,849 - 0.8 23,649 Common Stock
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2024 80,000 80,000 - - Stock Options
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.69 per share. 13 Mar 2024 144,906 833,849 - 0.7 100,000 Common Stock
Michael Chancellor Director, Chief Medical Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.69 per share. 13 Mar 2024 144,906 877,637 - 0.7 100,000 Common Stock
Daniel R. Cohen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 25,000 25,000 - - Stock Options
Naoki Yoshimura Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 25,000 25,000 - - Stock Options
Ryan Pruchnic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 25,000 25,000 - - Stock Options
Byong Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 25,000 25,000 - - Stock Options
Douglas Johnston Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 50,000 50,000 - - Options to Purchase
Michael Chancellor Director, Chief Medical Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 79,500 79,500 - - Stock Options
Jonathan Kaufman Director, See remarks below., Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 79,500 79,500 - - Stock Options
David S. Battleman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 25,000 25,000 - - Stock Options
Michael Chancellor Director, Chief Medical Officer, Ten Percent Owner Other type of transaction at price $ 5.75 per share. 22 Dec 2022 22,950 732,730 - 5.8 131,963 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters